Key Highlights
- ARK Invest acquired 51,477 Meta Platforms shares totaling approximately $38 million distributed across three ETFs
- Meta experienced an 11.5% rally on Monday, fueled by enthusiasm surrounding Muse, its innovative AI agent application
- ARK divested 28,403 CrowdStrike shares valued at approximately $7 million during the same trading session
- Despite CrowdStrike’s nearly 5% gain, ARK reduced its holdings in the cybersecurity firm
- Meta Connect conference scheduled for September 23-24, where Mark Zuckerberg will unveil AI initiatives and wearable technology
Cathie Wood’s ARK Invest executed two divergent portfolio adjustments on Monday, September 21, 2026. The investment firm accumulated a substantial position in Meta Platforms while simultaneously reducing its CrowdStrike holdings, despite both equities posting gains that day.
Meta’s stock price surged approximately 11.5% during Monday’s session. The rally was attributed to increasing attention on Muse, Meta’s newly unveiled personal AI agent platform. The application has climbed to the number one position on Apple’s U.S. free-app rankings, indicating strong early adoption among consumers.
Muse distinguishes itself from conventional chatbot technology. The AI agent can execute tasks including sending emails, arranging travel itineraries, completing digital forms, and conducting online transactions autonomously for users.
ARK purchased 51,477 shares of Meta distributed among its ARKK, ARKW, and ARKF exchange-traded funds. The total transaction value reached approximately $38 million.
The Meta Connect conference is set to take place September 23-24. CEO Mark Zuckerberg is anticipated to unveil additional AI products and wearable technology during the event, potentially providing investors with deeper insights into Muse’s roadmap and Meta’s comprehensive AI strategy.
Analyst sentiment on Meta remains overwhelmingly favorable. The stock carries a Strong Buy consensus rating from 44 Wall Street analysts, comprising 38 Buy recommendations and 6 Hold ratings. The consensus price target stands at $763.67, suggesting approximately 3% potential appreciation from current trading levels.
ARK Reduces CrowdStrike Exposure Amid Upward Momentum
CrowdStrike gained nearly 5% during Monday’s trading session. Cybersecurity equities benefited from projections that AI agent proliferation could increase the volume of digital access points requiring security infrastructure.
Notwithstanding the positive price movement, ARK divested 28,403 shares of CrowdStrike via its ARKW and ARKF funds. The divestment totaled approximately $7 million.
CrowdStrike recently conducted its Fal.Con conference. During the event, management unveiled new solutions designed for the AI agent landscape, including an Agentic Identity Provider and specialized products for securing AI computational workloads.
The cybersecurity company has demonstrated exceptional performance throughout 2026. Shares have appreciated approximately 113% year-to-date. Annual recurring revenue increased 25% to reach $5.84 billion in the most recent quarter, while net new ARR surged 51% to an all-time high of $333 million.
CrowdStrike similarly enjoys a Strong Buy consensus among Wall Street analysts, with 31 Buy ratings and 7 Hold ratings. The average analyst price target of $247.10 currently trades marginally below Monday’s closing price of $249.35.
ARK Executes Additional Healthcare Sector Transactions
In addition to the primary portfolio moves, ARK expanded positions across multiple biotechnology companies. The firm purchased 102,565 shares of Beam Therapeutics, 100,241 shares of Ionis Pharmaceuticals, and 74,878 shares of Veracyte via its ARKG ETF.
ARK also acquired 29,587 Airbnb shares through its ARKW ETF, representing a transaction value of approximately $4.9 million.
Among divestments, ARK reduced holdings in Everpure and 10x Genomics, and liquidated a modest quantity of ARK 21Shares Bitcoin ETF shares.
ARK additionally purchased 61,858 shares of Scribe Therapeutics, demonstrating sustained conviction in gene-editing innovation.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
